StreetAlpha.app
Home › Stocks › IKT

Inhibikase Therapeutics, Inc. (IKT)

$1.32
▲ +1.54%
LAST CLOSE · NOV 20

Inhibikase Therapeutics develops IKT-001, an oral drug candidate for pulmonary arterial hypertension, a rare lung blood vessel disease. It last closed at $1.32 on Nov 20, up 1.54% on the day. The next earnings report for IKT is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, IKT reported EPS of -$0.10. Over its last 8 reports the stock moved an average of 2.7% the session after earnings. Over the last 12 months IKT insiders bought $3.0M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is IKT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IKT.

Key Stats

Last 12 months
Results
Net income
−$69.2M
EPS (diluted)
−$0.40
−185.1% vs a year ago
Free cash flow
−$49.4M
Valuation
Market cap
$185.2M
140.3M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$51.7M
At Sep 30
Shareholder equity
$188.8M
Shares outstanding
140.3M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $3.1M$3.1MFY2021FY2022: $123K$123KFY2022FY2023: $261K$261KFY2023FY2024: $0$0FY2024

From IKT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Mar 25
Estimated date · After the close
Reported EPS
-$0.10
Quarter ended Sep 2026
Year ago EPS
-$0.13
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.87Dec '24Mar 2025: -$0.15Mar '25Jun 2025: -$0.11Jun '25Sep 2025: -$0.13Sep '25Dec 2025: -$0.09Dec '25Mar 2026: -$0.10Mar '26Jun 2026: -$0.11Jun '26Sep 2026: -$0.10Sep '26Latest -$0.10
Revenue by quarter
Dec 2024: $0Dec '24Mar 2025: $0Mar '25Jun 2025: $0Jun '25Sep 2025: $0Sep '25Mar 2026: $0Mar '26Jun 2026: $0Jun '26Latest $0
How IKT moved after its last 8 reports
Average move the session after a report ±2.7%
Nov 10, 2026After the close+5.2%
Aug 11, 2026After the close−2.0%
May 12, 2026After the close−1.0%
Mar 26, 2026After the close+3.1%
Nov 14, 2025After the close−0.7%
Aug 14, 2025After the close+2.3%
May 14, 2025After the close−4.3%
Mar 27, 2025After the close−3.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on IKTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on IKT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on IKT

Technical Analysis

IKT · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 14% below its 20 day and 36% below its 50 day average. It is 46% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the 52 week low at $1.28, and the nearest resistance the Pivot R1 at $1.37.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 9.2%/day
Key levels
$2.6152 week high+97.7%
$2.05100 day average+55.3%
$1.93200 day average+46.2%
$1.7950 day average+35.6%
$1.70Swing high (Oct 29)+28.8%
$1.5120 day average+14.4%
$1.37Pivot R1+3.8%
$1.32Pivot+0.0%
$1.32Last close
$1.2852 week low−3.0%
$1.28Pivot S1−3.0%
Indicators
RSI (14)34.85Weak, oversold below 30Neutral
MACD-0.12Below its signal lineBearish
Stochastic6.0Near the bottom of its rangeOversold
ADX (14)38.1Trending down
Williams %R-91.0Oversold below −80, overbought above −20Oversold
CCI (20)-187.9Oversold below −100, overbought above 100Oversold
Rate of change−12.0%Change over 10 sessionsBearish
ATR (14)$0.12Typical daily range, 9.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IKT

What happened before

See how IKT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow IKT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How IKT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for IKTHow many large options trades hit IKT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

IKT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲58 buying vs 39 selling
  • ▲Held by funds +2.2 pts
  • ▲Funds holding +4
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding110106+3.8%
In funds' top 10330.0%
Held by funds90.8%88.7%+2.2 pts
New / increased13 / 4519 / 49−14.7%
Reduced / sold out31 / 823 / 14+5.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IKT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

IKT Insider Trading

All filings →
Insider trading · 12 months
Insiders are buying
Bought$3.0M1 buy · 1 insider
Sold$00 sales · 0 insiders
DecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 21, 2025Frank M. Sands10% ownerBuy2,068,965$1.45$3.0M
Every insider buy and sale for IKT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See IKT insider trades →

From SEC Form 4 filings by IKT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IKT is in one of them and how their past IKT trades turned out.

IKT in the AI portfolios
Loading…

IKT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IKT in an article yet. Here's the latest on the wider market.

IKT in the news

About Inhibikase Therapeutics

Inhibikase Therapeutics is a pharmaceutical company developing treatments for pulmonary arterial hypertension, a rare and progressive disease that affects the blood vessels in the lungs. Its lead candidate, IKT-001, is an oral drug related to imatinib, a cancer medicine that has been used for many years. The company is running clinical trials of IKT-001 and has not yet sold a product. Its intended patients are people living with pulmonary arterial hypertension, and the company is based in Wilmington, Delaware.

Headquarters
Wilmington, DE